Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
HNRNPK Antisense RNA 1 (HNRNPK-AS1) is a gene that transcribes a long non-coding RNA classified as an antisense RNA relative to the HNRNPK gene. It belongs to the lncRNA class. Evidence currently links HNRNPK-AS1 primarily to genetic regulation at the RNA level, with potential but not definitively established roles in disease. It is cataloged as associated with conditions such as Au-Kline syndrome, although the mechanistic or causal involvement remains unclear. There is no evidence that it acts as a conventional drug target, nor is it associated with therapeutically actionable mechanisms at present[4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Heterogeneous nuclear ribonucleoprotein K antisense RNA 1 (HNRNPK-AS1).